This website contains promotional content and is intended for Healthcare Professionals in the Republic of Ireland only. Adverse event reporting can be found at the bottom of the page
{
event: "article_read",
name: `Identifying and treating patients with high lipidaemic risk post-ACS - Professor Perrone-Filardi`,
author: `Author`,
tags: ``,
publication_date: ``,
interaction_type: "content"
}
Article
Source: Campus Sanofi
Identifying and treating patients with high lipidaemic risk post-ACS - Professor Perrone-Filardi
Sanofi :Author
Editorial Team
Identifying and treating patients with high lipidaemic risk post-ACS
In the following video Professor Perrone- Filardi (Department of Clinical Medicine Cardiovascular and Immunology Sciences, Federico II University, Naples, Italy) discusses the topic of residual risk and the contribution of lipids, the importance of treating the post-ACS patients with lipid lowering therapy as soon as possible after their event.
You are going to a website that is not operated by Sanofi or a Sanofi website where the terms of use may differ. For external websites, Sanofi has no control over the content or availability of linked sites or resources, and accepts no liability or responsibility for them or for any loss or damage that may arise from your use of them. Please ensure that you read the legal and privacy policy sections of any third-party or Sanofi sites.
This site is intended for Healthcare Professionals in the Republic of Ireland and contains information on Sanofi Ireland medicine, educational resources and more. Please click the appropriate button below. By entering this site, you are confirming that you are a Healthcare Professional in the Republic of Ireland. This site contains promotional information.